Stay updated on Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedA new revision entry labeled v3.5.4 was added to the Record History, replacing the previous revision v3.5.3. This indicates an update to the study record and its version history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page footer’s revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision history updated from v3.5.0 to v3.5.2. This appears to be a backend version update with no visible content changes.SummaryDifference0.1%

- Check65 days agoChange DetectedThe Record History now shows a new revision entry v3.5.0 and removes the previous revision v3.4.3.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision v3.4.3 was added to the history and revision v3.4.2 was removed from the current history.SummaryDifference0.1%

- Check100 days agoChange DetectedAdded a new Revision: v3.4.2 to the history and removed the funding-lapse notice; the history now reflects the latest release and associated notices. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.